[HTML][HTML] Boosting therapeutic potency of antibodies by taming Fc domain functions
Monoclonal antibodies (mAbs) are one of the most widely used drug platforms for infectious
diseases or cancer therapeutics because they selectively target pathogens, infectious cells …
diseases or cancer therapeutics because they selectively target pathogens, infectious cells …
Boosting therapeutic potency of antibodies by taming Fc domain functions.
TH Kang, ST Jung - Experimental & Molecular Medicine …, 2019 - search.ebscohost.com
Monoclonal antibodies (mAbs) are one of the most widely used drug platforms for infectious
diseases or cancer therapeutics because they selectively target pathogens, infectious cells …
diseases or cancer therapeutics because they selectively target pathogens, infectious cells …
Boosting therapeutic potency of antibodies by taming Fc domain functions
TH Kang, ST Jung - EXPERIMENTAL AND MOLECULAR …, 2019 - scholar.korea.ac.kr
Monoclonal antibodies (mAbs) are one of the most widely used drug platforms for infectious
diseases or cancer therapeutics because they selectively target pathogens, infectious cells …
diseases or cancer therapeutics because they selectively target pathogens, infectious cells …
Boosting therapeutic potency of antibodies by taming Fc domain functions.
TH Kang, ST Jung - Experimental & Molecular Medicine, 2019 - europepmc.org
Monoclonal antibodies (mAbs) are one of the most widely used drug platforms for infectious
diseases or cancer therapeutics because they selectively target pathogens, infectious cells …
diseases or cancer therapeutics because they selectively target pathogens, infectious cells …
Boosting therapeutic potency of antibodies by taming Fc domain functions
TH Kang, ST Jung - Experimental & Molecular Medicine, 2019 - oldkmbase.medric.or.kr
Monoclonal antibodies (mAbs) are one of the most widely used drug platforms for infectious
diseases or cancer therapeutics because they selectively target pathogens, infectious cells …
diseases or cancer therapeutics because they selectively target pathogens, infectious cells …
Boosting therapeutic potency of antibodies by taming Fc domain functions
TH Kang, ST Jung - Experimental & molecular medicine, 2019 - pubmed.ncbi.nlm.nih.gov
Monoclonal antibodies (mAbs) are one of the most widely used drug platforms for infectious
diseases or cancer therapeutics because they selectively target pathogens, infectious cells …
diseases or cancer therapeutics because they selectively target pathogens, infectious cells …
Boosting therapeutic potency of antibodies by taming Fc domain functions
TH Kang, ST Jung - Experimental & Molecular Medicine, 2019 - search.proquest.com
Monoclonal antibodies (mAbs) are one of the most widely used drug platforms for infectious
diseases or cancer therapeutics because they selectively target pathogens, infectious cells …
diseases or cancer therapeutics because they selectively target pathogens, infectious cells …
Boosting therapeutic potency of antibodies by taming Fc domain functions
TH Kang, ST Jung - Experimental and Molecular Medicine, 2019 - pure.korea.ac.kr
Monoclonal antibodies (mAbs) are one of the most widely used drug platforms for infectious
diseases or cancer therapeutics because they selectively target pathogens, infectious cells …
diseases or cancer therapeutics because they selectively target pathogens, infectious cells …
Boosting therapeutic potency of antibodies by taming Fc domain functions
TH Kang, ST Jung - Experimental & Molecular Medicine, 2019 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Monoclonal antibodies (mAbs) are one of the
most widely used drug platforms for infectious diseases or cancer therapeutics because they …
most widely used drug platforms for infectious diseases or cancer therapeutics because they …
[HTML][HTML] Boosting therapeutic potency of antibodies by taming Fc domain functions
TH Kang, ST Jung - Experimental & Molecular Medicine, 2019 - ncbi.nlm.nih.gov
Monoclonal antibodies (mAbs) are one of the most widely used drug platforms for infectious
diseases or cancer therapeutics because they selectively target pathogens, infectious cells …
diseases or cancer therapeutics because they selectively target pathogens, infectious cells …